The diagnostic impact of UK regional variations in age-specific prostate-specific antigen guidelines

BJU Int. 2021 Sep;128(3):298-300. doi: 10.1111/bju.15484. Epub 2021 Jun 13.

Authors

Alexander Light^{1

2}, Nicholas Burns-Cox³, Angus Maccormick³, Joseph John⁴, John McGrath⁴, Vincent J Gnanapragasam^{1

2

5}

Affiliations

¹ Division of Urology, Department of Surgery, University of Cambridge, Cambridge, UK.
² Department of Urology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.
³ Department of Urology, Somerset NHS Foundation Trust, Taunton, UK.
⁴ Department of Urology, Royal Devon and Exeter NHS Foundation Trust, Exeter, UK.
⁵ Cambridge Urology Translational Research and Clinical Trials Office, Addenbrooke's Hospital, Cambridge, UK.

PMID: 34014596
DOI: 10.1111/bju.15484

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Age Factors
Aged
Aged, 80 and over
Humans
Male
Middle Aged
Practice Guidelines as Topic
Prostate-Specific Antigen
Prostatic Neoplasms / diagnosis*
United Kingdom

Substances

Prostate-Specific Antigen